OPTIMA-BP: Empowering PaTients in MAnaging Blood Pressure

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

200 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-09-29

Study Completion Date

2024-10-09

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Hypertension is the leading modifiable risk factor for cardiovascular disease and is implicated in half of all strokes and myocardial infarctions. One-third of adults in Scotland have hypertension yet only one-quarter of these have their blood pressure (BP) controlled to target (\<140/90 mmHg). Reasons for the low rate of control are varied but include individuals lack of confidence, knowledge and understanding of the condition and treatment strategy, non-adherence to medication and infrequent BP monitoring. These issues have been compounded by the ongoing COVID-19 pandemic which has brought changes in routine BP screening, access to medical care and chronic disease management in primary and secondary care, shielding of the highest risk groups and a change in health and research focus. Shared decision making and issues around health literacy were highlighted by the Scottish Government Cross Party Group on Heart Disease and Stroke: High Blood Pressure Task Force in 2019. Empowering patients to have a better understanding of their condition and becoming actively involved in the monitoring and management of hypertension may lead to improved patient satisfaction, improved BP control and health outcomes and reduction in the use of primary/secondary care hypertension clinics.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

OPtimizing Technology to Improve Medication Adherence and BP Control (OPTIMA-BP)

NCT05293756

Hypertension Self-Management Technology +1 more

RECRUITING NA

OPTImizing Precision of Hypertension Care to Maximize Blood Pressure Control Pilot (OPTI-BP Pilot)

NCT02814552

High Blood Pressure

COMPLETED NA

Piloting Healthcare Coordination in Hypertension

NCT02988193

Hypertension

COMPLETED NA

Data Collection and Evaluation of OptiBP Under Investigational Use

NCT06017687

General Population

RECRUITING NA

Evaluation of the Performance and Safety of the Aktiia Spot-check Optical Blood Pressure Monitoring Device At Wrist Against Double Auscultation

NCT06565780

Hypertension

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypertension

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Kvatchii Portal

The intervention group will be given access to the Kvatchii portal and home blood pressure monitor

Group Type ACTIVE_COMPARATOR

Kvatchii Portal

Intervention Type OTHER

Online education portal

Usual Care

The control group will not have access to the portal but will be provided with home blood pressure monitor

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Kvatchii Portal

Online education portal

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age ≥18
* Current attendance at the GBPC

Exclusion Criteria

* Inability to give informed consent
* Non-English speakers
* No internet access
* Clinic or ambulatory blood pressure ≥180/120 mmHg
* Arm circumference \>42cm
* Inability to perform HBPM
* Inability to use Kvatchii portal
* Pregnancy
* Persistent atrial fibrillation
* Acute cardiovascular event requiring hospitalisation in the previous 3 months
* CKD stage ≥4 or renal dialysis
* Severe or terminal illness limiting study participation

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No